Ichikawa Kenji | Department of Medicine II, Hokkaido University Graduate School of Medicine
スポンサーリンク
概要
- ICHIKAWA Kenjiの詳細を見る
- 同名の論文著者
- Department of Medicine II, Hokkaido University Graduate School of Medicineの論文著者
Department of Medicine II, Hokkaido University Graduate School of Medicine | 論文
- Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
- IFN-γ expression in CD8^+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4^+ T Cell death
- Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Polymyalgia rheumatica as the manifestation of unclassified aortitis